2-219435029-C-T
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting
The NM_005876.5(SPEG):c.52C>T(p.Pro18Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000293 in 1,500,184 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. P18P) has been classified as Likely benign.
Frequency
Consequence
NM_005876.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SPEG | NM_005876.5 | c.52C>T | p.Pro18Ser | missense_variant | 1/41 | ENST00000312358.12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SPEG | ENST00000312358.12 | c.52C>T | p.Pro18Ser | missense_variant | 1/41 | 5 | NM_005876.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000224 AC: 34AN: 152098Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000960 AC: 9AN: 93706Hom.: 0 AF XY: 0.000113 AC XY: 6AN XY: 52988
GnomAD4 exome AF: 0.000301 AC: 406AN: 1347976Hom.: 1 Cov.: 31 AF XY: 0.000280 AC XY: 186AN XY: 665022
GnomAD4 genome AF: 0.000223 AC: 34AN: 152208Hom.: 0 Cov.: 33 AF XY: 0.000255 AC XY: 19AN XY: 74426
ClinVar
Submissions by phenotype
Myopathy, centronuclear, 5 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | May 10, 2023 | - - |
not specified Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Genetic Services Laboratory, University of Chicago | Jun 27, 2022 | DNA sequence analysis of the SPEG gene demonstrated a sequence change, c.52C>T, in exon 1 that results in an amino acid change, p.Pro18Ser. This sequence change has been described in the gnomAD database with a frequency of 0.023% in the non-Finnish European subpopulation (dbSNP rs544959269). The p.Pro18Ser change affects a moderately conserved amino acid residue located in a domain of the SPEG protein that is not known to be functional. The p.Pro18Ser substitution appears to be benign using several in-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL). This sequence change does not appear to have been previously described in individuals with SPEG-related disorders. Due to insufficient evidences and the lack of functional studies, the clinical significance of the p.Pro18Ser change remains unknown at this time. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 07, 2021 | The c.52C>T (p.P18S) alteration is located in exon 1 (coding exon 1) of the SPEG gene. This alteration results from a C to T substitution at nucleotide position 52, causing the proline (P) at amino acid position 18 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 13, 2022 | This sequence change replaces proline, which is neutral and non-polar, with serine, which is neutral and polar, at codon 18 of the SPEG protein (p.Pro18Ser). This variant is present in population databases (rs544959269, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with SPEG-related conditions. ClinVar contains an entry for this variant (Variation ID: 1432832). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The serine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at